Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety and PK of AVYCAZ and Aztreonam Combination in Healthy Adults
NCT03978091Phase 2Completed
- Sponsor
- National Institute of Allergy and Infectious Diseases
- Start
- Jul 2019
- Primary completion
- Nov 2020
- Modality
- Irreversible Covalent Inhibitors
- Countries
- 1
01
Overview
A Phase 2 trial of ceftazidime + avibactam in bacterial infection, sponsored by National Institute of Allergy and Infectious Diseases. Started Jul 2019; status: completed.
02
Drugs
ceftazidime + avibactam
03
Conditions
bacterial infection
Beyond the preview
Go deeper on NCT03978091.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03978091.